Mark Wilterding, Chief Financial Officer at RxSight, Inc. (RXST), sold 7,765 shares at $6.96 ($54K) on 2026-09-02, disclosed to the SEC on 2026-09-02.
Open-market sale of $54k RXST by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.